Aptamer Group launches targeted radiopharmaceutical program

Aptamer Group launches targeted radiopharmaceutical program

Aptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a new targeted radiopharmaceutical program in collaboration with Radiopharmium Ltd, a UK-based specialist consultancy in radiopharmaceutical development.

Aptamer expands pipeline with targeted radiopharmaceutical initiative

Aptamer Group plc (LON:APTA), the developer of next‑generation synthetic binders for the life sciences industry, has announced the launch of a new programme to develop targeted radiopharmaceuticals, in collaboration with Radiopharmium Ltd, a UK-based consultancy providing specialist expertise, contacts and access to facilities in radiopharmaceutical development, from early research to manufacturing. Building a proprietary radiopharmaceutical pip…